date:May 10, 2012
vention to date, and our findings have potential clinical relevance.
Next up, we revisit our coverage of a potential game changer for the nutraceutical industry, according to ATM Metabolics. The Florida-based company is reportedly in advanced negotiations with some of the biggest food and beverage brands in the US and Europe about incorporating Emulin - the insulin-mimicking active ingredient in GNCs top-selling glucose control supplement GC7X - into packaged foods and drinks.
Other ingredient